Oppenheimer lowered the firm’s price target on Monroe Capital (MRCC) to $8 from $9 and keeps a Perform rating on the shares following quarterly results. The firm notes Monroe Capital lost (8c)/share in Q4, and says it estimates that it can earn $1.02/share and $1.00/share in 2025 and 2026, respectively, for an ROE of 11.5% and 11.3%.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRCC: